| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |